Kimberly J. Popovits

Ms Popovits has served as Chairman of the Board of Genomic Health since 2012, Chief Executive Officer and President since 2009, and President and Chief Operating Officer since 2002. Prior to joining Genomic Health, Ms Popovits served as Senior Vice President, Marketing and Sales, at Genentech, Inc. During her 15 years at Genentech, she led the commercialization of 14 new therapies, including Herceptin. She was named Woman of the Year in 2008 by the Women Health Care Executives and as one of the Most Influential Women in the Bay Area by the San Francisco Business Times from 2006-2012. Ms Popovits holds a bachelor of arts degree in business from Michigan State University.